197 related articles for article (PubMed ID: 23498364)
21. [Clinical and pathological prognostic factors for cancers of the esophagogastric junction].
Schmidt SC; Schlechtweg N; Veltzke-Schlieker W; Thuss-Patience P; Pratschke J; Neuhaus P; Schumacher G
Zentralbl Chir; 2009 Sep; 134(5):455-61. PubMed ID: 19757346
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for double primary malignancies and their clinical implications in patients with sporadic gastric cancer.
Cho I; An JY; Kwon IG; Choi YY; Cheong JH; Hyung WJ; Noh SH
Eur J Surg Oncol; 2014 Mar; 40(3):338-44. PubMed ID: 24342136
[TBL] [Abstract][Full Text] [Related]
23. Changing pattern of histological type, location, stage and outcome of surgical treatment of gastric carcinoma.
Borch K; Jönsson B; Tarpila E; Franzén T; Berglund J; Kullman E; Franzén L
Br J Surg; 2000 May; 87(5):618-26. PubMed ID: 10792320
[TBL] [Abstract][Full Text] [Related]
24. Current concepts in gastric cancer surgery.
Schumacher IK; Hunsicker A; Youssef PS; Lorenz D
Saudi Med J; 2002 Jan; 23(1):62-8. PubMed ID: 11938366
[TBL] [Abstract][Full Text] [Related]
25. Implications of overweight in gastric cancer: A multicenter study in a Western patient population.
Kulig J; Sierzega M; Kolodziejczyk P; Dadan J; Drews M; Fraczek M; Jeziorski A; Krawczyk M; Starzynska T; Wallner G;
Eur J Surg Oncol; 2010 Oct; 36(10):969-76. PubMed ID: 20727706
[TBL] [Abstract][Full Text] [Related]
26. Surgical outcomes and survival after extended multiorgan resection for T4 gastric cancer.
Mita K; Ito H; Fukumoto M; Murabayashi R; Koizumi K; Hayashi T; Kikuchi H
Am J Surg; 2012 Jan; 203(1):107-11. PubMed ID: 21474116
[TBL] [Abstract][Full Text] [Related]
27. Preoperative plasma fibrinogen levels in gastric cancer patients correlate with extent of tumor.
Lee JH; Ryu KW; Kim S; Bae JM
Hepatogastroenterology; 2004; 51(60):1860-3. PubMed ID: 15532844
[TBL] [Abstract][Full Text] [Related]
28. Surgical outcomes for colon and rectal cancer over a decade: results from a consecutive monocentric experience in 902 unselected patients.
Andreoni B; Chiappa A; Bertani E; Bellomi M; Orecchia R; Zampino M; Fazio N; Venturino M; Orsi F; Sonzogni A; Pace U; Monfardini L
World J Surg Oncol; 2007 Jul; 5():73. PubMed ID: 17610720
[TBL] [Abstract][Full Text] [Related]
29. Radiofrequency ablation for liver metastasis from gastric cancer.
Chen J; Tang Z; Dong X; Gao S; Fang H; Wu D; Xiang D; Zhang S
Eur J Surg Oncol; 2013 Jul; 39(7):701-6. PubMed ID: 23597495
[TBL] [Abstract][Full Text] [Related]
30. The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter series.
Marchet A; Mocellin S; Ambrosi A; de Manzoni G; Di Leo A; Marrelli D; Roviello F; Morgagni P; Saragoni L; Natalini G; De Santis F; Baiocchi L; Coniglio A; Nitti D;
Eur J Surg Oncol; 2008 Feb; 34(2):159-65. PubMed ID: 17566691
[TBL] [Abstract][Full Text] [Related]
31. Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma.
Chou YY; Jeng YM; Lee TT; Hu FC; Kao HL; Lin WC; Lai PL; Hu RH; Yuan RH
Ann Surg Oncol; 2007 Oct; 14(10):2748-58. PubMed ID: 17680316
[TBL] [Abstract][Full Text] [Related]
32. Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation.
Piessen G; Messager M; Leteurtre E; Jean-Pierre T; Mariette C
Ann Surg; 2009 Dec; 250(6):878-87. PubMed ID: 19855261
[TBL] [Abstract][Full Text] [Related]
33. Differentiated-type predominant mixed-histology-type early gastric cancer is a significant risk factor for endoscopic non-curative resection regardless of tumor size.
Isomoto H
Dig Endosc; 2018 Sep; 30(5):602-604. PubMed ID: 29808612
[No Abstract] [Full Text] [Related]
34. Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma.
Okuwaki Y; Nakazawa T; Kokubu S; Hidaka H; Tanaka Y; Takada J; Watanabe M; Shibuya A; Minamino T; Saigenji K
Am J Gastroenterol; 2009 Nov; 104(11):2747-53. PubMed ID: 19603009
[TBL] [Abstract][Full Text] [Related]
35. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.
Asoglu O; Karanlik H; Parlak M; Kecer M; Muslumanoglu M; Igci A; Ozmen V; Gulluoglu M; Kapran Y
Hepatogastroenterology; 2009; 56(91-92):908-13. PubMed ID: 19621727
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors for survival in patients with hepatic recurrence after curative resection of gastric cancer.
Hwang SE; Yang DH; Kim CY
World J Surg; 2009 Jul; 33(7):1468-72. PubMed ID: 19381718
[TBL] [Abstract][Full Text] [Related]
37. Prognostic role of lymphatic vessel invasion in early gastric cancer: a retrospective study of 188 cases.
Liu C; Zhang R; Lu Y; Li H; Lu P; Yao F; Jin F; Xu H; Wang S; Chen J
Surg Oncol; 2010 Mar; 19(1):4-10. PubMed ID: 19042124
[TBL] [Abstract][Full Text] [Related]
38. Impact of tumour location and surgical approach on recurrence-free and cancer-specific survival analysis in patients with ureteric tumours.
Bin X; Roy OP; Ghiraldi E; Manglik N; Liang T; Vira M; Kavoussi LR
BJU Int; 2012 Dec; 110(11 Pt B):E514-9. PubMed ID: 22578024
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological features and outcome of surgical treatment of 149 patients with early (pT1) gastric cancer.
Skoropad V; Berdov B; Zagrebin V
Onkologie; 2005 May; 28(5):247-52. PubMed ID: 15867480
[TBL] [Abstract][Full Text] [Related]
40. Different patterns of recurrence in gastric cancer depending on Lauren's histological type: longitudinal study.
Marrelli D; Roviello F; de Manzoni G; Morgagni P; Di Leo A; Saragoni L; De Stefano A; Folli S; Cordiano C; Pinto E;
World J Surg; 2002 Sep; 26(9):1160-5. PubMed ID: 12209247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
